OneBlood is the first blood center to get full FDA approval to give high-titer COVID-19 convalescent plasma to those with COVID-19 who are also immunocompromised.

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify ...

In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with ...

Human metapneumovirus (hMPV) cases continue to be reported in several states across India, although the number of cases is ...

Thiruvananthapuram: Kerala Chief Minister Pinarayi Vijayan on Thursday addressed the Opposition's allegations regarding the ...

The Health Department of Northwest Michigan is reporting an increase in respiratory illnesses across Antrim, Charlevoix, ...

The peptide, which is a short chain of amino acids, has shown effectiveness in experiments involving various coronavirus ...

Don’t practice teledermatology on patients you’ve never seen before,” Dr. David J. Goldberg advised. “That’s the easiest way to stay out of trouble.” ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Despite a rise in the number of individuals needing treatment for substance use disorder in the United States, treatment ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...